399 related articles for article (PubMed ID: 7802081)
1. Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: effects of the oxytocin antagonist atosiban.
Bossmar T; Akerlund M; Fantoni G; Szamatowicz J; Melin P; Maggi M
Am J Obstet Gynecol; 1994 Dec; 171(6):1634-42. PubMed ID: 7802081
[TBL] [Abstract][Full Text] [Related]
2. Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women.
Akerlund M; Bossmar T; Brouard R; Kostrzewska A; Laudanski T; Lemancewicz A; Serradeil-Le Gal C; Steinwall M
Br J Obstet Gynaecol; 1999 Oct; 106(10):1047-53. PubMed ID: 10519430
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of barusiban and atosiban on oxytocin-induced contractions of myometrium from preterm and term pregnant women.
Pierzynski P; Lemancewicz A; Reinheimer T; Akerlund M; Laudanski T
J Soc Gynecol Investig; 2004 Sep; 11(6):384-7. PubMed ID: 15350251
[TBL] [Abstract][Full Text] [Related]
4. The effect on the human uterus of two newly developed competitive inhibitors of oxytocin and vasopressin.
Akerlund M; Carlsson AM; Melin P; Trojnar J
Acta Obstet Gynecol Scand; 1985; 64(6):499-504. PubMed ID: 4061066
[TBL] [Abstract][Full Text] [Related]
5. Human myometrium during pregnancy contains and responds to V1 vasopressin receptors as well as oxytocin receptors.
Maggi M; Del Carlo P; Fantoni G; Giannini S; Torrisi C; Casparis D; Massi G; Serio M
J Clin Endocrinol Metab; 1990 Apr; 70(4):1142-54. PubMed ID: 2156888
[TBL] [Abstract][Full Text] [Related]
6. Effects of the non-peptide inhibitor OPC-21268 on oxytocin and vasopressin stimulation of rat and human myometrium.
Atke A; Vilhardt H; Hauzerova L; Barth T; Andersen LF
Eur J Pharmacol; 1995 Jul; 281(1):63-8. PubMed ID: 8566118
[TBL] [Abstract][Full Text] [Related]
7. Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea.
Akerlund M; Melin P; Maggi M
Adv Exp Med Biol; 1995; 395():595-600. PubMed ID: 8714023
[TBL] [Abstract][Full Text] [Related]
8. Involvement of oxytocin and vasopressin in the pathophysiology of preterm labor and primary dysmenorrhea.
Akerlund M
Prog Brain Res; 2002; 139():359-65. PubMed ID: 12436949
[TBL] [Abstract][Full Text] [Related]
9. Treatment of preterm labor with the oxytocin and vasopressin antagonist Atosiban.
Bossmar T
J Perinat Med; 1998; 26(6):458-65. PubMed ID: 10224602
[TBL] [Abstract][Full Text] [Related]
10. Antagonists for the human oxytocin receptor: an in vitro study.
Maggi M; Fantoni G; Baldi E; Cioni A; Rossi S; Vannelli GB; Melin P; Akerlund M; Serio M
J Reprod Fertil; 1994 Jul; 101(2):345-52. PubMed ID: 7932368
[TBL] [Abstract][Full Text] [Related]
11. The combination tocolytic effect of magnesium sulfate and an oxytocin receptor antagonist in myometrium from singleton and twin pregnancies.
Arrowsmith S; Neilson J; Wray S
Am J Obstet Gynecol; 2016 Dec; 215(6):789.e1-789.e9. PubMed ID: 27555315
[TBL] [Abstract][Full Text] [Related]
12. FE 200 440: a selective oxytocin antagonist on the term-pregnant human uterus.
Nilsson L; Reinheimer T; Steinwall M; Akerlund M
BJOG; 2003 Nov; 110(11):1025-8. PubMed ID: 14592588
[TBL] [Abstract][Full Text] [Related]
13. Effect of oxytocin receptor and beta2-adrenoceptor blockade on myometrial oxytocin receptors in parturient rats.
Engstrøm T; Bratholm P; Vilhardt H; Christensen NJ
Biol Reprod; 1999 Feb; 60(2):322-9. PubMed ID: 9915997
[TBL] [Abstract][Full Text] [Related]
14. Synthetic antagonists of the myometrial response to vasopressin and oxytocin.
Melin P; Trojnar J; Johansson B; Vilhardt H; Akerlund M
J Endocrinol; 1986 Oct; 111(1):125-31. PubMed ID: 3783079
[TBL] [Abstract][Full Text] [Related]
15. Review on prostaglandin and oxytocin activity in preterm labor.
Ivanisević M; Djelmis J; Buković D
Coll Antropol; 2001 Dec; 25(2):687-94. PubMed ID: 11811300
[TBL] [Abstract][Full Text] [Related]
16. Oxytocin receptor blockade: a new principle in the treatment of preterm labor?
Andersen LF; Lyndrup J; Akerlund M; Melin P
Am J Perinatol; 1989 Apr; 6(2):196-9. PubMed ID: 2540760
[TBL] [Abstract][Full Text] [Related]
17. Vasopressin and oxytocin in normal reproduction and in the pathophysiology of preterm labour and primary dysmenorrhoea. Development of receptor antagonists for therapeutic use in these conditions.
Akerlund M
Rocz Akad Med Bialymst; 2004; 49():18-21. PubMed ID: 15631309
[TBL] [Abstract][Full Text] [Related]
18. Effect of the oxytocin antagonist atosiban (1-deamino-2-D-tyr(OET)-4-thr-8-orn-vasotocin/oxytocin) on nocturanl myometrial contractions, maternal cardiovascular function, transplacental passage, and fetal oxygenation in the pregnant baboon during the last third of gestation.
Nathanielsz PW; Honnebier MB; Mecenas C; Jenkins SL; Holland ML; Demarest K
Biol Reprod; 1997 Aug; 57(2):320-4. PubMed ID: 9241045
[TBL] [Abstract][Full Text] [Related]
19. Receptor-mediated uterine effects of vasopressin and oxytocin in nonpregnant women.
Bossmar T; Akerlund M; Szamatowicz J; Laudanski T; Fantoni G; Maggi M
Br J Obstet Gynaecol; 1995 Nov; 102(11):907-12. PubMed ID: 8534628
[TBL] [Abstract][Full Text] [Related]
20. Differential Effects of Oxytocin Receptor Antagonists, Atosiban and Nolasiban, on Oxytocin Receptor-Mediated Signaling in Human Amnion and Myometrium.
Kim SH; Pohl O; Chollet A; Gotteland JP; Fairhurst AD; Bennett PR; Terzidou V
Mol Pharmacol; 2017 Apr; 91(4):403-415. PubMed ID: 28188254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
